Cargando…
Summary of the published Indian data on chronic myeloid leukemia
Chronic myelogenous leukemia (LML) was recognized as a distinct entity in the mid-1800s. Since Nowell and Hunagerford initiated their research on CML in1960 our understanding in CML has been increasing. Imatinib became the preferred treatment from 2000 onwards as a result of its unprecedented succes...
Autores principales: | Singhal, Manish K., Sengar, Manju, Nair, Reena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991141/ https://www.ncbi.nlm.nih.gov/pubmed/27606306 http://dx.doi.org/10.4103/2278-330X.187593 |
Ejemplares similares
-
Gynecological cancers: A summary of published Indian data
por: Maheshwari, Amita, et al.
Publicado: (2016) -
Indian data on bone and soft tissue sarcomas: A summary of published study results
por: Ramaswamy, Anant, et al.
Publicado: (2016) -
Indian data on central nervous tumors: A summary of published work
por: Dasgupta, Archya, et al.
Publicado: (2016) -
Therapeutic drug monitoring for imatinib: Current status and Indian experience
por: Arora, Brijesh, et al.
Publicado: (2013) -
Chronic myeloid leukemia: An Indian scenario
por: Digumarti, Raghunadharao
Publicado: (2016)